Sartorius | Bioprocess Solutions dans l'actualité
Technologies de bioprocédés pour les biopharmaceutiques
Tamtam a trouvé 20 articles récents sur Sartorius | Bioprocess Solutions.
- RBC keeps EUR 220.00 target for Sartorius stock
- Berenberg raises Sartorius target to EUR 280.00: Sartorius stock falls 2.01 percent
- Sartorius stock reports 7.7 percent H1 sales growth
- Sartorius (XTRA:SRT3) Could Be 29% Below Fair Value After Conference Focus
- Sartorius Stedim Biotech Updates Share Capital and Voting Rights Structure
- Bioprocess Sampling Connectors Market Outlook to 2035
- Sartorius stock holds steady as DAX constituent with bioprocessing focus
- Single-Use Bioprocess Bags Market Outlook to 2035
- Sartorius stock holds steady as investors digest latest bioprocessing trends
- CHO perfusion model lifts yield by letting cellular waste build up
- Sartorius (XTRA:SRT3) Posted Stronger Earnings, Is It Still Below Fair Value?
- What Sartorius (XTRA:SRT3)'s Stronger Profit Growth Than Sales Means For Shareholders
- Sartorius Aktiengesellschaft Q2 Earnings Call Highlights
- Sartorius stock trades steady as investors weigh valuation against recent earnings trends
- Sartorius AG Revenue Breakdown – HAM:SRT
- Sartorius stock steadies as investors weigh margin recovery and bioprocess demand
- Sartorius Aktiengesellschaft (SRT.DE) Stock Price, News, Quote & History
- Sartorius Aktiengesellschaft Q2 Earnings Call Highlights
- Sartorius H1 2026 slides: strong growth masked by tariff effects
- Sartorius H1 FY26 net profit climbs 50.9% to EUR 122.2 million; revenue rises 2.5% to EUR 1.81 billion
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme Sartorius | Bioprocess Solutions ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires